On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Franco Trevisani

ResearcherPublications, citations & collaboration network

Franco Trevisani is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Franco Trevisani have?

ScholarIQindexed works

Franco Trevisani has 696 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Franco Trevisani have?

ScholarIQcitation count

Franco Trevisani has 17,613 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Franco Trevisani?

ScholarIQh-index

Franco Trevisani has an h-index of 75 in OpenAlex.

What is the i10-index of Franco Trevisani?

ScholarIQi10-index

Franco Trevisani has an i10-index of 223 in OpenAlex.

What is the ORCID of Franco Trevisani?

ScholarIQorcid

The ORCID for Franco Trevisani is on the source record.

What is the OpenAlex record for Franco Trevisani?

ScholarIQopenalex

The OpenAlex for Franco Trevisani is on the source record.

What are the most-cited papers on Franco Trevisani?

ScholarIQmost cited works
Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled Trials
Calogero Cammà, Filippo Schepis, Ambrogio Orlando, Maddalena Albanese, Lillian Shahied, Franco Trevisani, Pietro Andreoné, Antonio Craxı̀, Mario Cottone
Radiology. 2002851 CitationsOPEN ACCESS
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
on behalf of the PRECISION ITALIA STUDY GROUP, Rita Golfieri, Emanuela Giampalma, Matteo Renzulli, Roberto Cioni, Irene Bargellini, Carlo Bartolozzi, Andrea Doriguzzi Breatta, G Gandini, Roberto Nani, Daniele Gasparini, Alessandro Cucchetti, Luigi Bolondi, Franco Trevisani
British Journal of Cancer. 2014606 CitationsOPEN ACCESS
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
Alessandro Vitale, Giuseppe Cabibbo, Massimo Iavarone, Luca Viganò, David J. Pinato, Francesca Romana Ponziani, Quirino Lai, Andrea Casadei‐Gardini, Ciro Celsa, Giovanni Galati, Martina Gambato, Laura Crocetti, Matteo Renzulli, Edoardo G. Giannini, Fabio Farinati, Franco Trevisani, Umberto Cillo, Umberto Baccarani, Giuseppina Brancaccio, Raffaele Cozzolongo, Alessandro Cucchetti, Nicoletta De Matthaeis, Stefano Di Sandro, Simone Famularo, Michele Finotti, Francesco Giuseppe Foschi, Davide Ghinolfi, Marco Guarracino, Salvatore Gruttadauria, Maria Guarino, Alba Kostandini, Ilaria Lenci, Giovanni Battista Levi Sandri, Tommaso Maria Manzia, Giovanni Marasco, Mario Masarone, Chiara Mazzarelli, Fabio Melandro, Luca Miele, Filomena Morisco, Daniele Nicolini, Duilio Pagano, Filippo Pelizzaro, Giulia Pieri, Fabio Piscaglia, Maria Corina Plaz Torres, Riccardo Pravisani, Maria Rendina, Fabrizio Romano, Francesco Paolo Russo, Rodolfo Sacco, Angelo Sangiovanni, Carlo Sposito, Raffaella Tortora, Francesco Tovoli, Mauro Viganò, Paola Violi
The Lancet Oncology. 2023192 Citations
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study
Alessandro Vitale, Rafael Morales, Giacomo Zanus, Fabio Farinati, Patrizia Burra, Paolo Angeli, Anna Chiara Frigo, P. Del Poggio, Gianludovico Rapaccini, Maria Anna Di Nolfo, Luisa Benvegnù, Marco Zoli, Franco Borzio, Edoardo G. Giannini, Eugenio Caturelli, Maria Chiaramonte, Franco Trevisani, Umberto Cillo
The Lancet Oncology. 2011155 Citations

Related on ScholarIQ

470M+ articles · free account